awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26771682-CC1DC27A-C89C-478D-8BE0-B83F7CCA36B7
Q26771682-CC1DC27A-C89C-478D-8BE0-B83F7CCA36B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771682-CC1DC27A-C89C-478D-8BE0-B83F7CCA36B7
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
P2860
Q26771682-CC1DC27A-C89C-478D-8BE0-B83F7CCA36B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771682-CC1DC27A-C89C-478D-8BE0-B83F7CCA36B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
084e2b29e6d5157b468de3d22abfd299e2d73269
P2860
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)